These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
236 related articles for article (PubMed ID: 7674020)
1. A more potent bystander cytocidal effect elicited by tumor cells expressing the herpes simplex virus-thymidine kinase gene than by fibroblast virus-producer cells in vitro. Vrionis FD; Wu JK; Qi P; Cano W; Cherington V J Neurosurg; 1995 Oct; 83(4):698-704. PubMed ID: 7674020 [TBL] [Abstract][Full Text] [Related]
2. Preservation of the bystander cytocidal effect of irradiated herpes simplex virus thymidine kinase (HSV-tk) modified tumor cells. Vrionis FD; Wu JK; Qi P; Cano WG; Cherington V J Neurooncol; 1996 Dec; 30(3):225-36. PubMed ID: 8943097 [TBL] [Abstract][Full Text] [Related]
3. Tumor cells expressing the herpes simplex virus-thymidine kinase gene in the treatment of Walker 256 meningeal neoplasia in rats. Vrionis FD; Wu JK; Qi P; Cano WG; Cherington V J Neurosurg; 1996 Feb; 84(2):250-7. PubMed ID: 8592228 [TBL] [Abstract][Full Text] [Related]
4. Intravenous RMP-7 increases delivery of ganciclovir into rat brain tumors and enhances the effects of herpes simplex virus thymidine kinase gene therapy. LeMay DR; Kittaka M; Gordon EM; Gray B; Stins MF; McComb JG; Jovanovic S; Tabrizi P; Weiss MH; Bartus R; Anderson WF; Zlokovic BV Hum Gene Ther; 1998 May; 9(7):989-95. PubMed ID: 9607410 [TBL] [Abstract][Full Text] [Related]
5. Retrovirus-mediated herpes simplex virus thymidine kinase gene transduction renders human thyroid carcinoma cell lines sensitive to ganciclovir and radiation in vitro and in vivo. Nishihara E; Nagayama Y; Mawatari F; Tanaka K; Namba H; Niwa M; Yamashita S Endocrinology; 1997 Nov; 138(11):4577-83. PubMed ID: 9348181 [TBL] [Abstract][Full Text] [Related]
6. Mechanisms for ganciclovir resistance in gastrointestinal tumor cells transduced with a retroviral vector containing the herpes simplex virus thymidine kinase gene. Yang L; Hwang R; Chiang Y; Gordon EM; Anderson WF; Parekh D Clin Cancer Res; 1998 Mar; 4(3):731-41. PubMed ID: 9533543 [TBL] [Abstract][Full Text] [Related]
7. [Bystander effect mediated by herpes simplex virus-thymidine kinase/ganciclovir approach on prostatic cancer cells and its regulation]. Xing Y; Lu G; Xiao Y; Zeng F; Zhang Q; Xiong P; Feng W Zhonghua Yi Xue Za Zhi; 2002 Nov; 82(21):1484-7. PubMed ID: 12509912 [TBL] [Abstract][Full Text] [Related]
8. Bystander tumoricidal effect in the treatment of experimental brain tumors. Wu JK; Cano WG; Meylaerts SA; Qi P; Vrionis F; Cherington V Neurosurgery; 1994 Dec; 35(6):1094-102; discussion 1102-3. PubMed ID: 7885554 [TBL] [Abstract][Full Text] [Related]
9. In situ generation of pseudotyped retroviral progeny by adenovirus-mediated transduction of tumor cells enhances the killing effect of HSV-tk suicide gene therapy in vitro and in vivo. Okada T; Caplen NJ; Ramsey WJ; Onodera M; Shimazaki K; Nomoto T; Ajalli R; Wildner O; Morris J; Kume A; Hamada H; Blaese RM; Ozawa K J Gene Med; 2004 Mar; 6(3):288-99. PubMed ID: 15026990 [TBL] [Abstract][Full Text] [Related]
10. Experimental study of the RV-HSV-TK/GCV suicide gene therapy system in gastric cancer. Tang Q; Zhang D; Wan M; Jin L Cancer Biother Radiopharm; 2007 Dec; 22(6):755-61. PubMed ID: 18158766 [TBL] [Abstract][Full Text] [Related]
11. Effect of herpes simplex virus thymidine kinase expression levels on ganciclovir-mediated cytotoxicity and the "bystander effect". Chen CY; Chang YN; Ryan P; Linscott M; McGarrity GJ; Chiang YL Hum Gene Ther; 1995 Nov; 6(11):1467-76. PubMed ID: 8573619 [TBL] [Abstract][Full Text] [Related]
12. The "bystander effect": tumor regression when a fraction of the tumor mass is genetically modified. Freeman SM; Abboud CN; Whartenby KA; Packman CH; Koeplin DS; Moolten FL; Abraham GN Cancer Res; 1993 Nov; 53(21):5274-83. PubMed ID: 8221662 [TBL] [Abstract][Full Text] [Related]
13. Gene therapy of malignant brain tumors: a rat glioma line bearing the herpes simplex virus type 1-thymidine kinase gene and wild type retrovirus kills other tumor cells. Takamiya Y; Short MP; Ezzeddine ZD; Moolten FL; Breakefield XO; Martuza RL J Neurosci Res; 1992 Nov; 33(3):493-503. PubMed ID: 1335091 [TBL] [Abstract][Full Text] [Related]
14. The role of cytokines in mediating the bystander effect using HSV-TK xenogeneic cells. Freeman SM; Ramesh R; Shastri M; Munshi A; Jensen AK; Marrogi AJ Cancer Lett; 1995 Jun; 92(2):167-74. PubMed ID: 7600527 [TBL] [Abstract][Full Text] [Related]
15. Retrovirus-mediated gene therapy of experimental brain neoplasms using the herpes simplex virus-thymidine kinase/ganciclovir paradigm. Rainov NG; Kramm CM; Aboody-Guterman K; Chase M; Ueki K; Louis DN; Harsh GR; Chiocca A; Breakefield XO Cancer Gene Ther; 1996; 3(2):99-106. PubMed ID: 8729908 [TBL] [Abstract][Full Text] [Related]
16. Expression of costimulatory molecules: B7 and ICAM up-regulation after treatment with a suicide gene. Ramesh R; Munshi A; Abboud CN; Marrogi AJ; Freeman SM Cancer Gene Ther; 1996; 3(6):373-84. PubMed ID: 8988840 [TBL] [Abstract][Full Text] [Related]
17. In situ retroviral-mediated gene transfer for the treatment of brain tumors in rats. Ram Z; Culver KW; Walbridge S; Blaese RM; Oldfield EH Cancer Res; 1993 Jan; 53(1):83-8. PubMed ID: 8380127 [TBL] [Abstract][Full Text] [Related]
18. Retrovirus-mediated suicide gene transduction in the vitreous cavity of the eye: feasibility in prevention of proliferative vitreoretinopathy. Kimura H; Sakamoto T; Cardillo JA; Spee C; Hinton DR; Gordon EM; Anderson WF; Ryan SJ Hum Gene Ther; 1996 May; 7(7):799-808. PubMed ID: 8860832 [TBL] [Abstract][Full Text] [Related]
19. Limitations of retrovirus-mediated HSV-tk gene transfer to pulmonary adenocarcinoma cells in vitro and in vivo. Zhang L; Wikenheiser KA; Whitsett JA Hum Gene Ther; 1997 Mar; 8(5):563-74. PubMed ID: 9095408 [TBL] [Abstract][Full Text] [Related]